NA
NXTM

Neuburgh Advisers’s NxStage Medical Inc. NXTM Stock Holding History

Neuburgh Advisers’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,784
Closed -$69K – 921
2018
Q1 		$69K Sell
2,784
-8,432
-75% -$205K ﹤0.01% 828
2017
Q4 		$272K Sell
11,216
-8,032
-42% -$212K 0.01% 580
2017
Q3 		$531K Sell
19,248
-2,400
-11% -$64K 0.02% 380
2017
Q2 		$543K Sell
21,648
-7,216
-25% -$179K 0.02% 375
2017
Q1 		$774K Hold
28,864
– – 0.03% 303
2016
Q4 		$756K Buy
+28,864
New +$714K 0.03% 277

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Neuburgh Advisers's NXTM Position: Q2 2018 in Review

Neuburgh Advisers sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 2,784 shares — an estimated $69K sold.

Neuburgh Advisers first reported a position in NXTM in Q4 2016 and held it in 6 quarters. The position peaked at $774K in Q1 2017. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

  • Neuburgh Advisers reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
  • Neuburgh Advisers sold 2,784 NxStage Medical Inc. shares in Q2 2018, an estimated $69K.
  • Neuburgh Advisers first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 6 quarters.
  • Neuburgh Advisers's NxStage Medical Inc. position peaked at $774K in Q1 2017.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on Neuburgh Advisers's 13F filing for Q2 2018, filed 10 Aug 2018.